NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs

In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout

Altasciences and Certara forge strategic pact to speed early drug development

6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders

Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption

ICMR launches fellowship programme for biomedical scientists from developing countries

Initiative aims to strengthen South-South collaboration and capacity building in biomedical research

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy

ADMA Biologics wins FDA nod to expand ASCENIV use in young children

MSD launches cervical cancer awareness campaign with Madhuri Dixit Nene

The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness

Swasth Bharat Portal launched by Jagat Prakash Nadda

Conceptualized as an aggregator platform it integrates existing programme systems through an API-based federated architecture

Gufic Biosciences deepens global oncology push with fresh investment in Australia’s Selvax

Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology